Literature DB >> 8551453

Healon GV versus Healon in demanding cataract surgery.

A Caporossi1, S Baiocchi, C Sforzi, R Frezzotti.   

Abstract

This study compared how well two sodium hyaluronate viscoelastics maintained the anterior chamber during cataract surgery in eyes at risk for high vitreous pressure. Patients were divided into two groups based on the sodium hyaluronate used: Healon or Healon GV. Qualitative data were obtained with a digital slide gauge attached to the operating microscope. After capsulorhexis, mean anterior chamber depth (distance of the corneal apex to the iris plane) was significantly greater in the Healon GV group (P = .0012). Subjective intraoperative evaluation by surgeons also favored Healon GV. There was no difference between the groups in postoperative inflammation, corneal edema, intraocular pressure, or visual acuity. Therefore, although the two viscoelastics are equally safe, Healon GV maintains the anterior chamber better during cataract surgery.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8551453     DOI: 10.1016/s0886-3350(13)80572-x

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  3 in total

Review 1.  Hyaluronic Acid: Perspectives in Upper Aero-Digestive Tract. A Systematic Review.

Authors:  Manuele Casale; Antonio Moffa; Lorenzo Sabatino; Annalisa Pace; Giuseppe Oliveto; Massimiliano Vitali; Peter Baptista; Fabrizio Salvinelli
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

2.  Addition Of D-Sorbitol Improves The Usability Of Ophthalmic Viscosurgical Devices.

Authors:  Ippei Watanabe; Mayumi Nagata; Hiroyuki Matsushima
Journal:  Clin Ophthalmol       Date:  2019-09-23

3.  Quantitative Assessment of Ophthalmic Viscosurgical Devices on Visibility, Spreadability, and Durability as Corneal Wetting Agents for the Wet Shell Technique.

Authors:  Ippei Watanabe; Hirotaka Hoshi; Kiyoshi Suzuki; Mayumi Nagata; Hiroyuki Matsushima
Journal:  Ophthalmol Ther       Date:  2020-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.